United States · FDA National Drug Code directory
CALQUENCE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-4513_7365aa18-60da-4ce6-9c06-01c80e158286
- Product NDC
- 0310-4513
- Form
- TABLET, FILM COATED
- Composition / generic term
- acalabrutinib
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220804
- Source listing expiry
- 20271231
Source-listed ingredients
- ACALABRUTINIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (0310-4513-60) · 0310-4513-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →